Table 1.
Demographics of study cohort
| Age | |
|---|---|
| Mean (SD) | 56 (15.3) |
| Median (IQR) | 58 (44‐66) |
| Male patients, no. (%) | 50 (83.3) |
| ASA score | |
| Mean (SD) | 1.67 (0.63) |
| Median (IQR) | 2 (1‐2) |
| Co‐morbidities, no (%) | 24 (40) |
| Hypertension | 13 (21.7) |
| Ischaemic heart disease | 3 (5.0) |
| Hyperchlosterolaemia | 7 (11.7) |
| Diabetes mellitus | 5 (8.4) |
| Asthma, COPD | 4 (6.7) |
| ConT disease (sarcoidosis, PMR) | 2 (3.3) |
| Other cancer (rectal , prostate) | 5 (8.4) |
| Not recorded | 6 (10) |
| Presentation, no (%) | |
| Incidental (LUTS, health screen, cardiac imaging, research volunteer, testicular pain, weight loss) | 34 (56.7) |
| Haematuria | 8 (13.3) |
| Urinary tract infection | 5 (8.3) |
| Loin pain | 4 (6.7) |
| Surveillance scan (other cancer) | 4 (6.7) |
| Not recorded | 5 (8.3) |
SD = standard deviation; IQR = Inter Quartile Range; ASA = American Society of Anesthesiology; COPD = chronic obstructive pulmonary disease; ConT = connective tissue; PMR = polymyalgia rheumatica; LUTS = lower urinary tract symptoms